These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9775485)
21. Prevalence of prostate cancer among men aged 40+ living in Osman Gazi health care district. Çeber E; Şimşir A; Umar DÇ; Karababa AO; Günaydın G; Çal Ç; Özentürk G Asian Pac J Cancer Prev; 2010; 11(2):473-8. PubMed ID: 20843136 [TBL] [Abstract][Full Text] [Related]
22. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Lim LS; Sherin K; Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648 [TBL] [Abstract][Full Text] [Related]
23. Psychological benefits of prostate cancer screening: the role of reassurance. Cantor SB; Volk RJ; Cass AR; Gilani J; Spann SJ Health Expect; 2002 Jun; 5(2):104-13. PubMed ID: 12031051 [TBL] [Abstract][Full Text] [Related]
24. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States. Tourville EA; Nguyen MM Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941 [TBL] [Abstract][Full Text] [Related]
25. A church-based program on prostate cancer screening for African American men: reducing health disparities. Husaini BA; Reece MC; Emerson JS; Scales S; Hull PC; Levine RS Ethn Dis; 2008; 18(2 Suppl 2):S2-179-84. PubMed ID: 18646345 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658 [TBL] [Abstract][Full Text] [Related]
27. Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Eisen SA; Waterman B; Skinner CS; Scherrer JF; Romeis JC; Bucholz K; Heath A; Goldberg J; Lyons MJ; Tsuang MT; True WR Urology; 1999 Mar; 53(3):516-22. PubMed ID: 10096377 [TBL] [Abstract][Full Text] [Related]
28. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923 [TBL] [Abstract][Full Text] [Related]
29. Barriers and facilitators of prostate cancer screening among Filipino men in Hawaii. Conde FA; Landier W; Ishida D; Bell R; Cuaresma CF; Misola J Oncol Nurs Forum; 2011 Mar; 38(2):227-33. PubMed ID: 21356660 [TBL] [Abstract][Full Text] [Related]
30. Prostate Cancer Screening. Dunn MW Semin Oncol Nurs; 2017 May; 33(2):156-164. PubMed ID: 28343840 [TBL] [Abstract][Full Text] [Related]
31. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997. McDavid K; Melnik TA; Derderian H Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632 [TBL] [Abstract][Full Text] [Related]
33. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Weller D; Pinnock C; Silagy C; Hiller JE; Marshall VR Aust N Z J Public Health; 1998; 22(3 Suppl):400-2. PubMed ID: 9629831 [TBL] [Abstract][Full Text] [Related]
34. Prostate cancer education in African American churches. Weinrich S; Holdford D; Boyd M; Creanga D; Cover K; Johnson A; Frank-Stromborg M; Weinrich M Public Health Nurs; 1998 Jun; 15(3):188-95. PubMed ID: 9629032 [TBL] [Abstract][Full Text] [Related]
35. The impact of informed consent on patient interest in prostate-specific antigen screening. Wolf AM; Nasser JF; Wolf AM; Schorling JB Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843 [TBL] [Abstract][Full Text] [Related]
36. Percent free PSA as an additional measure in a prostate cancer screen. Miele ME Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982 [TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK; J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007 [TBL] [Abstract][Full Text] [Related]
38. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Merrill RM Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662 [TBL] [Abstract][Full Text] [Related]
39. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL. Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057 [TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study. Bretton PR South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]